ALKYLAMINE

Alkyl Amines Chemicals Limited

Alkyl Amines Chemicals Limited (ALKYLAMINE) financial statements and selected valuation metrics through 30 June 2026.

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

alkylamines.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1844.70
Market cap
9,436 Cr
Stock P/E
41.9
P/B
6.15
Dividend yield
0.5%
ROE (FY20)
37.5%
ROCE (FY20)
43.8%
Operating margin (FY20)
23.2%
Debt / equity (FY20)
0.09
OCF / EBITDA (FY26)
83.8%
OCF / EBITDA (3Y)
94.0%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Alkyl Amines makes specialty chemicals, mainly methylamines, ethylamines, their derivatives and acetonitrile, sold largely to pharma and agrochemical makers.

Company snapshot

16thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓Net margin of 20.3% — the business keeps a healthy share of every rupee it earns.
4 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales352 Cr322 Cr357 Cr400 Cr415 Cr371 Cr386 Cr406 Cr389 Cr354 Cr387 Cr528 Cr
Operating expenses (approx.)304 Cr262 Cr288 Cr321 Cr341 Cr300 Cr318 Cr329 Cr319 Cr287 Cr316 Cr394 Cr
EBITDA48 Cr60 Cr69 Cr79 Cr74 Cr71 Cr68 Cr77 Cr70 Cr67 Cr71 Cr134 Cr
OPM %13.7%18.5%19.3%19.8%17.7%19.2%17.6%18.9%18.0%19.0%18.3%25.3%
Other income2 Cr5 Cr3 Cr5 Cr9 Cr7 Cr9 Cr8 Cr7 Cr8 Cr8 Cr9 Cr
Interest2 Cr1 Cr0.71 Cr0.21 Cr0.35 Cr0.85 Cr0.17 Cr0.30 Cr0.34 Cr0.24 Cr0.29 Cr0.39 Cr
Depreciation13 Cr17 Cr17 Cr18 Cr18 Cr18 Cr18 Cr18 Cr18 Cr18 Cr18 Cr18 Cr
Profit before tax36 Cr46 Cr53 Cr66 Cr64 Cr59 Cr59 Cr66 Cr59 Cr57 Cr61 Cr125 Cr
Tax %25.2%27.8%27.9%25.9%26.2%25.9%22.5%25.5%27.4%26.2%25.4%24.1%
Net profit27 Cr33 Cr38 Cr49 Cr47 Cr44 Cr46 Cr49 Cr43 Cr42 Cr45 Cr95 Cr
EPS (₹)₹5.33₹6.54₹7.52₹9.56₹9.28₹8.56₹9.00₹9.67₹8.40₹8.26₹8.87₹18.50

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales542 Cr625 Cr846 Cr993 Cr1,242 Cr1,543 Cr1,682 Cr1,441 Cr1,572 Cr1,536 CrSign in free for the trailing twelve months
Operating expenses (approx.)447 Cr508 Cr682 Cr736 Cr813 Cr1,216 Cr1,339 Cr1,190 Cr1,281 Cr1,251 CrSign in free for the trailing twelve months
EBITDA95 Cr116 Cr164 Cr257 Cr429 Cr327 Cr343 Cr251 Cr291 Cr285 CrSign in free for the trailing twelve months
OPM %17.6%18.6%19.4%25.9%34.5%21.2%20.4%17.4%18.5%18.5%Sign in free for the trailing twelve months
Other income1 Cr3 Cr4 Cr7 Cr7 Cr14 Cr14 Cr15 Cr30 Cr32 CrSign in free for the trailing twelve months
Interest8 Cr8 Cr15 Cr10 Cr6 Cr4 Cr3 Cr4 Cr1 Cr1 CrSign in free for the trailing twelve months
Depreciation14 Cr16 Cr23 Cr27 Cr29 Cr35 Cr45 Cr59 Cr71 Cr72 CrSign in free for the trailing twelve months
Profit before tax74 Cr96 Cr130 Cr260 Cr401 Cr302 Cr309 Cr202 Cr249 Cr243 CrSign in free for the trailing twelve months
Tax %31.9%32.9%35.7%17.1%26.3%25.6%25.9%26.5%25.1%26.1%Sign in free for the trailing twelve months
Net profit50 Cr64 Cr84 Cr215 Cr295 Cr225 Cr229 Cr149 Cr186 Cr180 CrSign in free for the trailing twelve months
EPS (₹)₹24.69₹31.15₹41.06₹105.55₹144.68₹44.04₹44.75₹29.13₹36.40₹35.20Sign in free for the trailing twelve months
Dividend payout %————13.8%13.6%22.3%34.3%27.5%28.4%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr
Reserves235 Cr287 Cr355 Cr526 Cr782 Cr980 Cr1,159 Cr1,257 Cr1,392 Cr1,523 Cr
Borrowings100 Cr151 Cr128 Cr48 Cr22 Cr23 Cr85 Cr0.64 Cr4 Cr—
Other liabilities166 Cr189 Cr255 Cr199 Cr331 Cr359 Cr336 Cr316 Cr383 Cr362 Cr
Total liabilities512 Cr637 Cr749 Cr783 Cr1,145 Cr1,371 Cr1,590 Cr1,584 Cr1,789 Cr1,895 Cr
Fixed assets (net)219 Cr354 Cr376 Cr422 Cr457 Cr627 Cr716 Cr1,085 Cr1,041 Cr1,012 Cr
CWIP35 Cr18 Cr43 Cr45 Cr138 Cr142 Cr352 Cr36 Cr52 Cr130 Cr
Investments1 Cr1 Cr1 Cr0 Cr30 Cr0 Cr0 Cr0 Cr0 Cr51 Cr
Loans & advances——0.20 Cr0.23 Cr0.15 Cr0.16 Cr0.13 Cr0.10 Cr0.08 Cr0.05 Cr
Inventories111 Cr85 Cr106 Cr84 Cr122 Cr165 Cr184 Cr172 Cr165 Cr122 Cr
Trade receivables97 Cr124 Cr153 Cr164 Cr228 Cr277 Cr258 Cr222 Cr231 Cr231 Cr
Cash & bank2 Cr2 Cr19 Cr31 Cr96 Cr38 Cr17 Cr30 Cr49 Cr94 Cr
Other assets46 Cr52 Cr51 Cr37 Cr74 Cr122 Cr63 Cr38 Cr251 Cr255 Cr
Total assets512 Cr637 Cr749 Cr783 Cr1,145 Cr1,371 Cr1,590 Cr1,584 Cr1,789 Cr1,895 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity63 Cr102 Cr144 Cr188 Cr364 Cr205 Cr248 Cr275 Cr263 Cr239 Cr
Cash from investing-65 Cr-132 Cr-67 Cr-41 Cr-213 Cr-206 Cr-277 Cr-121 Cr-196 Cr-137 Cr
Cash from financing-2 Cr32 Cr-60 Cr-135 Cr-86 Cr-57 Cr8 Cr-140 Cr-49 Cr-56 Cr
Net cash flow-3 Cr2 Cr17 Cr12 Cr65 Cr-58 Cr-21 Cr13 Cr18 Cr45 Cr
Free cash flow (OCF − Capex)-3 Cr-34 Cr75 Cr110 Cr208 Cr-42 Cr-55 Cr153 Cr215 Cr110 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020
ROCE %23.4%23.0%29.0%43.8%
ROE %20.3%21.3%22.7%37.5%
Debtor days65726660
Inventory days155968064
Days payable112769454
Cash conversion cycle108925270
OCF / EBITDA %66.7%87.3%87.7%73.0%
OCF / EBITDA % (3 years)——82.3%80.6%
Debt / equity0.390.490.340.09
Current ratio1.401.331.261.91
Net debt / EBITDA1.03—0.660.06